The company reported total revenue growth of 8% at constant exchange rates for the third quarter of fiscal 2025, and confirmed its guidance for the year.

The sale decreases Pfizer’s shareholding in the consumer-healthcare business to 7.3% of its issued share capital, down from 15%.

Eli Lilly cut its outlook for fourth-quarter revenue citing sluggish growth in the market for incretin, which increases insulin levels.

CEOs are angling for invites to parties, which include the MAHA ball and another with Snoop Dogg.

The MySports package includes access to many major sports, but some holes remain.

An offer is probably months away from happening.